Condition
Lipid Disorders
Total Trials
5
Recruiting
1
Active
1
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
75% success
Data Visualizations
Phase Distribution
3Total
P 1 (1)
P 4 (2)
Trial Status
Completed3
Recruiting1
Terminated1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT02311335CompletedPrimary
Genes Involved in Lipid Disorders
NCT06747000RecruitingPrimary
Lipoprotein Interactions and Platelet Function in Healthy Individuals and Those With Lipid Disorders
NCT01543269Phase 1Terminated
A Clinical Study to Evaluate the Safety,Tolerability and PK of ZYT1, Following Oral Administration in Healthy Volunteers
NCT00841217Phase 4Completed
Regulation of Lipoprotein Transport in Metabolic Syndrome
NCT00632840Phase 4Completed
Pharmacological Regulation of Fat Transport in Metabolic Syndrome
Showing all 5 trials